The OCRP Investigator-Initiated Research Award is intended to support high-impact research that has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project.
The anticipated direct costs budgeted for the entire period of performance for an FY17 OCRP Investigator-Initiated Research award will not exceed $450,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer. Although not required, investigators are encouraged to address one of the FY17 Areas of Encouragement in their applications:
• Novel therapies and associated predictive biomarkers
• Non-invasive surveillance and assessment of disease
• Treatment resistance
• Etiology, epidemiology, and prevention
• Early detection
• Rare subtypes
• Host-tumor interactions
• Survivorship and quality of life